INTRODUCTION
Primary ciliary dyskinesia (PCD), also known as immotile cilia syndrome is a rare, genetically determined disease (predominantly inherited as an autosomal recessive) mostly interfering with upper and lower respiratory tract. It is associated in 40-50% with visceral situs inversus and other forms of heterotaxy (1) . Symptoms of the disease directly result from impaired ciliary clearance.
Unfortunately disorders due to dysmotile cilia have been poorly studied in children. Therapeutic strategies are taken from the algorithms developed for the treatment of cystic fibrosis (CF). Lower requirement for more PCD research is the consequence.
DISCUSSION
CD is determined by a number of different genetic ciliary defects (tab. 1) that result in ineffective mucociliary clearance.
Most patients with PCD have symptoms since their birth or early infancy (2), but the diagnosis is usually postponed (3). Significant number of patients are never diagnosed (4). It seems likely (but stays unproven) that early diagnosis of PCD is important as deterioration in lung function can largely be prevented by specialist respiratory care (5).
How to recognise a young child at risk of developing bronchiectasis? The important sign is that of a persistent "wet" sounding cough. Especially if such a cough persists for more than 8 weeks or symptoms return when antibiotic treatment is stopped. In patients with PCD the cough never goes completely away even with treatment. Likewise, chronic upper airway symptoms, such as constant rhinitis (nasal discharge, episodic facial pain and anosmia). Ear symp- Diagnosis, due to the lack of standardisation and inaccessibility stays challenging either for the patient or the paediatrician. Screening tests for PCD do exist but they are uncorrelated. There are number of problems and the biggest is that most of the screening tests are unreliable in children. For the moment, the most sensitive and specific screening test for PCD is measurement of nasal nitric oxide ( fig. 1 ) (9-11) but even along special paediatric program it is dedicated for children older than 5 years of age (as well as radioaerosol mucociliary clearance tests). What specialist centres may offer to their patients as diagnostic test? First: obtaining a sample of ciliate cells by nasal brushing or bronchoscopic samples. Then analysis of ciliary function by ciliary beat pattern and frequency analysis, evaluation of the cilia's structure on electron microscopy and even genetic analysis (12). Diagnostic algorithm is presented on figure 2. Chronic mucopurulent sputum production is common Digital clubbing may also be found Pulmonary function tests usually show a progressive obstructive or mixed pattern Nasal polyposis and halitosis Infertility in males (-50%) due to immotility of spermatozoa ectopic pregnancy and subfertility in females Fig. 1 . Nasal nitric oxidemeasurement due to CF and sinusitis test results. Based on (10).
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Primary ciliary dyskinesia: how to diagnose, how to treat Restore or maintain normal lung function is the main aim of therapy for PCD. Unfortunately there are no randomised trials of adequate treatment. Therefore recommendations are based on a very low level evidence. The clinician should abort therapy that is not working. Main, valid guidelines for the therapy are: -airway clearance by combinations of physiotherapy and physical exercise should be encouraged and regularly prescribed in children with PCD (11, 12), -high-dose oral antibiotics should be prescribed at the first sign of worsening respiratory symptoms or deterioration in lung function; if persistent respiratory symptoms do not respond to oral antibiotics, then intravenous therapy should be given (8), -anti-inflammatory strategies, such as alternate-day prednisolone or inhaled corticosteroids, should not be used (12, 13), -Otitis media with effusion should be managed conservatively, with regular audiological assessment, hearing aids and hearing therapy (14, 15), -the use of ventilation tubes (grommets) should be avoided where possible (8, 14, 15), -regular (≥ 3 monthly) sputum or cough-swab cultures should be performed based on clinic and hospital or local colonisation (8).
To deliver best care, patients with PCD should be seen for either full or shared care in a centre specialising in the condition. There is urgent need to publicize information about syndrome itself, about reference centres and diagnostic methods. Further studies are clearly needed to establish general consensus statement. CONCLUSIONS 1. The primary ciliary dyskinesia is rarely taking under consideration in the differential diagnosis of chronic/ recurrent upper respiratory tract infections. 2. Available screening tests do not include target group of patients (< 12 y.o.). 3. No recommendations for the type and methods of obtaining material for testing and methods of its transportation. 4. The basic diagnostic limitation is high cost of a conclusive tests. 5. There is necessity to differentiate primary and secondary ciliary dyskinesia. 6. No general algorithm running patients diagnosed with PCD -the mandatory introduction of standard therapy.
